Ex ISRO Chairman G. Madhavan Nair Inaugurated the Latest Cancer Radiation therapy technology – LINAC At MVRCCRI.

May 31, 2017 by mvradmin0

June 12, 2017: Ex ISRO Chairman G. Madhavan Nair Inaugurated the Latest Cancer  Radiation therapy technology – Linear acceleator machine (Linac) at MVRCCRI today.

Linear acceleator machine (Linac) which is the most modern radiation therapy treatment machine for cancer, will be installed at MVR Cancer Centre and Research Institute (MVRCCRI) in June 2017.

With the installation of Linac, the time taken for radiation treatment will be reduced from the current 8-15 minutes to 2 minutes. The Linac has been installed with an online monitoring system called dolphin dosimetry to ensure that the treatment received is perfect. This is the first time that a hospital in India is installing this facility.

Other treatment facilities available in the Linac include Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Volumetric Modulated Arc Therapy (VMAT), Stereotactic Radio Surgery (SRS), Stereotactic Radiation Therapy (SRT) Stereotactic Body Radiotherapy (SBRT), Total Skin Electron Therapy (TSET), and so on.

During the progress of radiation treatment, the Linac assesses the progress and makes sure that the treatment concentrates on the affected part in order to ensure that the other parts of the body are not affected making it extremely safe for patients.


Leave a Reply

Your email address will not be published. Required fields are marked *

9 − 2 =


whitelogofooter2

The MVRCCRI, set up by the Care Foundation initiated by City Service Cooperative Bank, is situated on 15.5 acre property at Vellasseri in Kozhikode district with 300 bed strength spread over six lakhs square feet area. The Centre is named after the late CMP leader M. V. Raghavan. Inaugurated on January 17 2017, both the OP and IP departments are functional from January 18 2017. The Hospital established at a cost of INR 350 Crore has spent INR 150 crore for acquiring the latest Equipment.

© MVR Cancer Centre and Research Institute 2017. All rights reserved.